|
|
|
|
|
|
|
|
|
|
Current Oncology (Canada)
SUMMARY AND FUTURE DIRECTIONS
The integration and broader utilization of
cannabinoid therapies within the domain of oncology (including
palliation) carries the potential not only for improved health care
outcomes for patients but also for economic savings and greater safety
for society90,94.
Patient reports of improvement in quality of life, especially for those
undergoing intensive treatment regimens, could be key to patients
continuing with lifesaving or life-prolonging therapies. Cannabinoids
might be able to help patients throughout their disease trajectory, but
evidence about the ideal timing for cannabinoid initiation is lacking.
Enrolment in clinical trials will help to answer many of those
questions, and it can be hoped that support (financial and otherwise)
from the medical community will increase as the public’s acceptance of
medical cannabis use broadens. More research will guide oncology and
palliative care teams in their pursuit of excellence in cancer and
symptomatic care.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.